BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

982 related articles for article (PubMed ID: 16787254)

  • 1. The cardiac hERG/IKr potassium channel as pharmacological target: structure, function, regulation, and clinical applications.
    Thomas D; Karle CA; Kiehn J
    Curr Pharm Des; 2006; 12(18):2271-83. PubMed ID: 16787254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [HERG K+ channel, the target of anti-arrhythmias drugs].
    Guan FY; Yang SJ
    Yao Xue Xue Bao; 2007 Jul; 42(7):687-91. PubMed ID: 17882949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of HERG potassium channel function by drug action.
    Thomas D; Karle CA; Kiehn J
    Ann Med; 2004; 36 Suppl 1():41-6. PubMed ID: 15176423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Susceptibilities of Human Ether-à-Go-Go-Related Gene Channel with the G487R Mutation to Arrhythmogenic Factors.
    Hisajima N; Hata Y; Kinoshita K; Fukushima T; Nishida N; Kano M; Tabata T
    Biol Pharm Bull; 2015; 38(5):781-4. PubMed ID: 25947924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Familial and acquired long qt syndrome and the cardiac rapid delayed rectifier potassium current.
    Witchel HJ; Hancox JC
    Clin Exp Pharmacol Physiol; 2000 Oct; 27(10):753-66. PubMed ID: 11022966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In silico prediction of the chemical block of human ether-a-go-go-related gene (hERG) K+ current.
    Inanobe A; Kamiya N; Murakami S; Fukunishi Y; Nakamura H; Kurachi Y
    J Physiol Sci; 2008 Dec; 58(7):459-70. PubMed ID: 19032804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The hERG potassium channel as a therapeutic target.
    Witchel HJ
    Expert Opin Ther Targets; 2007 Mar; 11(3):321-36. PubMed ID: 17298291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Facilitation of hERG Activation by Its Blocker: A Mechanism to Reduce Drug-Induced Proarrhythmic Risk.
    Furutani K
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. hERG potassium channels and cardiac arrhythmia.
    Sanguinetti MC; Tristani-Firouzi M
    Nature; 2006 Mar; 440(7083):463-9. PubMed ID: 16554806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac hERG K
    Su S; Sun J; Wang Y; Xu Y
    Handb Exp Pharmacol; 2021; 267():139-166. PubMed ID: 33829343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Progress in research on defective protein trafficking and functional restoration in HERG-associated long QT syndrome].
    Fang P; Lian J
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2016 Feb; 33(1):101-4. PubMed ID: 26829745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. hERG K(+) channels: structure, function, and clinical significance.
    Vandenberg JI; Perry MD; Perrin MJ; Mann SA; Ke Y; Hill AP
    Physiol Rev; 2012 Jul; 92(3):1393-478. PubMed ID: 22988594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-affinity blockade of human ether-a-go-go-related gene human cardiac potassium channels by the novel antiarrhythmic drug BRL-32872.
    Thomas D; Wendt-Nordahl G; Röckl K; Ficker E; Brown AM; Kiehn J
    J Pharmacol Exp Ther; 2001 May; 297(2):753-61. PubMed ID: 11303067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV Tat protein inhibits hERG K+ channels: a potential mechanism of HIV infection induced LQTs.
    Bai YL; Liu HB; Sun B; Zhang Y; Li Q; Hu CW; Zhu JX; Gong DM; Teng X; Zhang Q; Yang BF; Dong DL
    J Mol Cell Cardiol; 2011 Nov; 51(5):876-80. PubMed ID: 21820442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In silico screening of the impact of hERG channel kinetic abnormalities on channel block and susceptibility to acquired long QT syndrome.
    Romero L; Trenor B; Yang PC; Saiz J; Clancy CE
    J Mol Cell Cardiol; 2014 Jul; 72():126-37. PubMed ID: 24631769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular determinants of cocaine block of human ether-á-go-go-related gene potassium channels.
    Guo J; Gang H; Zhang S
    J Pharmacol Exp Ther; 2006 May; 317(2):865-74. PubMed ID: 16397089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The hERG channel activator, RPR260243, enhances protective
    Shi YP; Pang Z; Venkateshappa R; Gunawan M; Kemp J; Truong E; Chang C; Lin E; Shafaattalab S; Faizi S; Rayani K; Tibbits GF; Claydon VE; Claydon TW
    Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H251-H261. PubMed ID: 32559136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the activation gate in determining the extracellular potassium dependency of block of HERG by trapped drugs.
    Pareja K; Chu E; Dodyk K; Richter K; Miller A
    Channels (Austin); 2013 Jan; 7(1):23-33. PubMed ID: 23221912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. hERG: protein trafficking and potential for therapy and drug side effects.
    Staudacher I; Schweizer PA; Katus HA; Thomas D
    Curr Opin Drug Discov Devel; 2010 Jan; 13(1):23-30. PubMed ID: 20047143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-terminal HERG (LQT2) mutations disrupt IKr channel regulation through 14-3-3epsilon.
    Choe CU; Schulze-Bahr E; Neu A; Xu J; Zhu ZI; Sauter K; Bähring R; Priori S; Guicheney P; Mönnig G; Neapolitano C; Heidemann J; Clancy CE; Pongs O; Isbrandt D
    Hum Mol Genet; 2006 Oct; 15(19):2888-902. PubMed ID: 16923798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.